FDA Inspection 1239760 - Regeneron Pharmaceuticals Inc - February 16, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Regeneron Pharmaceuticals Inc, with an inspection on February 16, 2024, issued by the New York District Office, covering human drugs.

Company: Regeneron Pharmaceuticals Inc
Inspection Date: February 16, 2024
Product Type: Human Drugs
Office: New York District Office

Open in Dashboard

ID · be92bc21-d599-4a82-9b9d-dde944acebd3